IL307220A - Rifamycin analogs in combination with vancomycin and their uses - Google Patents

Rifamycin analogs in combination with vancomycin and their uses

Info

Publication number
IL307220A
IL307220A IL307220A IL30722023A IL307220A IL 307220 A IL307220 A IL 307220A IL 307220 A IL307220 A IL 307220A IL 30722023 A IL30722023 A IL 30722023A IL 307220 A IL307220 A IL 307220A
Authority
IL
Israel
Prior art keywords
vancomycin
combination
rifamycin analogs
rifamycin
analogs
Prior art date
Application number
IL307220A
Other languages
English (en)
Hebrew (he)
Inventor
Thomas Nittoli
Anna Zumsteg
Original Assignee
Regeneron Pharma
Thomas Nittoli
Anna Zumsteg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma, Thomas Nittoli, Anna Zumsteg filed Critical Regeneron Pharma
Publication of IL307220A publication Critical patent/IL307220A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL307220A 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and their uses IL307220A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163166597P 2021-03-26 2021-03-26
PCT/US2022/021922 WO2022204499A1 (en) 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and uses thereof

Publications (1)

Publication Number Publication Date
IL307220A true IL307220A (en) 2023-11-01

Family

ID=81308077

Family Applications (1)

Application Number Title Priority Date Filing Date
IL307220A IL307220A (en) 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and their uses

Country Status (14)

Country Link
US (1) US20240189319A1 (https=)
EP (1) EP4313060B1 (https=)
JP (1) JP2024511165A (https=)
KR (1) KR20230162654A (https=)
CN (1) CN117098540A (https=)
AU (1) AU2022246161A1 (https=)
BR (1) BR112023019720A2 (https=)
CA (1) CA3213382A1 (https=)
CL (1) CL2023002840A1 (https=)
CO (1) CO2023013406A2 (https=)
ES (1) ES3017798T3 (https=)
IL (1) IL307220A (https=)
MX (1) MX2023011328A (https=)
WO (1) WO2022204499A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024221162A1 (zh) * 2023-04-24 2024-10-31 丹诺医药(苏州)有限公司 化合物预防关节假体周围感染的方法
KR20260012505A (ko) 2024-07-18 2026-01-27 이화여자대학교 산학협력단 기계 학습을 이용한 반코마이신 초회 투여량 적합성 판단 시스템 및 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118955710A (zh) * 2018-05-09 2024-11-15 里珍纳龙药品有限公司 抗msr1抗体及其使用方法
PH12021551476A1 (en) * 2018-12-21 2022-04-25 Regeneron Pharma Rifamycin analogs and antibody-drug conjugates thereof

Also Published As

Publication number Publication date
US20240189319A1 (en) 2024-06-13
CN117098540A (zh) 2023-11-21
BR112023019720A2 (pt) 2024-01-23
CO2023013406A2 (es) 2023-10-30
AU2022246161A1 (en) 2023-10-12
KR20230162654A (ko) 2023-11-28
ES3017798T3 (en) 2025-05-13
CA3213382A1 (en) 2022-09-29
WO2022204499A1 (en) 2022-09-29
MX2023011328A (es) 2023-12-14
CL2023002840A1 (es) 2024-03-15
EP4313060A1 (en) 2024-02-07
JP2024511165A (ja) 2024-03-12
EP4313060B1 (en) 2025-03-05

Similar Documents

Publication Publication Date Title
GB2581987B (en) Use of cannabidiol in combination with antibiotics
IL257706A (en) Peptidomimetic macrocycles and their uses
PL3359396T3 (pl) Elastomer dienowy mający funkcję w środku łańcucha i zawierająca go kompozycja kauczuku
IL254444A0 (en) Peptidomimetic macrocycles and their uses
IL275037A (en) CRISPR-CAS9-modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
EP3397101A4 (en) HELMET WITH BORDER TOP AND ELASTOMER BRACKETS
PT3408317T (pt) Espuma de um copolímero de blocos poliamida e blocos poliéter
IL307220A (en) Rifamycin analogs in combination with vancomycin and their uses
HUE067446T2 (hu) Rapamicin analógok és alkalmazásaik
GB202200959D0 (en) Polypeptides having anti-senescent effects and uses thereof
GB202002010D0 (en) Microtopographies and uses thereof
SG11202107846XA (en) Cyclosporin analog and use thereof
DK3965616T5 (da) Siddemøbel med wall-away-funktion og udsvingbar foddel
IL299732A (en) Macrocycles and their use
GB201819850D0 (en) Polypeptide and its use in affinity purification
PL3874959T3 (pl) Kompozycja do żywienia do stosowania w celu poprawy sprawności poznawczej i/lub zapobiegania upośledzeniu funkcji poznawczych
EP4317174A4 (en) PEPTIDE AND COMPOSITION CONTAINING A PEPTIDE
IL309885A (en) Alpha-surface polypeptides and their use
EP3947418C0 (en) PEPTIDES AND THEIR USE
PL3628802T3 (pl) Układ klamki wychylnej z pierwszym i drugim mechanizmem blokującym
SG10202101479PA (en) Peptides with vasodilatory and/or diuretic functions
GB202106040D0 (en) Methods and uses
GB202103872D0 (en) Uses and methods
GB202019660D0 (en) Uses and methods
GB202100996D0 (en) Ezrin-derived peptides and uses